羧胺三唑乳清酸盐对人胰腺癌细胞系增殖及脂肪酸合成代谢的影响

doi:10.16352/j.issn.1001-6325.2024.04.0440

基础医学与临床 ›› 2024, Vol. 44 ›› Issue (4): 440-446.doi: 10.16352/j.issn.1001-6325.2024.04.0440

羧胺三唑乳清酸盐对人胰腺癌细胞系增殖及脂肪酸合成代谢的影响

郭泓江, 徐也婷, 张迪雅, 仇佳星, 王钰铖, 鞠瑞^*, 郭磊^*

中国医学科学院基础医学研究所北京协和医学院基础学院药理学系,北京 100005

收稿日期:2023-12-01 修回日期:2024-01-23 出版日期:2024-04-05 发布日期:2024-03-25
通讯作者: ^*jurui1984@163.com;leiguo@ibms.cams.cn
基金资助:
国家自然科学基金(82002094);中国医学科学院医学与健康科技创新工程(2022-I2M-2-002);北京市自然科学基金(7222254)

Effect of carboxyamidotriazole-orotate on proliferation and fatty acid anabolism of human pancreatic cancer cell lines

GUO Hongjiang, XU Yeting, ZHANG Diya, QIU Jiaxing, WANG Yucheng, JU Rui^*, GUO Lei^*

Department of Pharmacology,Institute of Basic Medical Sciences CAMS,School of Basic Medicine PUMC,Beijing 100005,China

Received:2023-12-01 Revised:2024-01-23 Online:2024-04-05 Published:2024-03-25
Contact: ^*jurui1984@163.com;leiguo@ibms.cams.cn

摘要/Abstract

摘要： 目的研究羧胺三唑乳清酸盐(CTO)对人胰腺癌细胞增殖影响及对其脂肪酸合成代谢的调控作用。方法以人胰腺癌细胞系AsPC-1、AsPC-1/GEM(简称AR)、PANC-1、MiaPaCa-2为研究对象,用磺酰罗丹明B(SRB)检测细胞存活率,采用qPCR检测胰腺癌细胞系中脂肪酸合成关键基因mRNA水平,用Western blot检测细胞内腺苷单磷酸依赖蛋白激酶(AMPK)和乙酰辅酶A羧化酶(ACC)通路蛋白表达;利用液相色谱-质谱联用代谢组学技术检测细胞内脂质代谢物质差异。结果与对照组相比,CTO显著降低AsPC-1、AR、PANC-1、MiaPaCa-2 4株人胰腺癌细胞活率(P＜0.05); CTO下调细胞内脂肪酸合成关键基因的mRNA水平(P＜0.05);CTO下调细胞中AMPK、ACC及c-Myc蛋白表达(P＜0.05),而增加p-AMPK、p-ACC蛋白表达(P＜0.05);CTO减少AR细胞中脂质代谢物含量(P＜0.05)。结论 CTO通过抑制癌基因c-Myc蛋白表达及AMPK/ACC通路,下调脂肪酸合成相关基因的表达活性,减弱细胞脂肪酸合成代谢能力,进而抑制人胰腺癌细胞系AsPC-1、AR、PANC-1、MiaPaCa-2的增殖能力。

关键词: 羧胺三唑乳清酸盐, 胰腺癌, 增殖, 脂肪酸合成代谢

Abstract: Objective To study the effect of carboxyamidotriazole-orotate(CTO) on the proliferation and fatty acid anabolism regulation of human pancreatic cancer cells. Methods Human pancreatic cancer cell lines AsPC-1, AsPC-1/GEM(AR), PANC-1 and MiaPaCa-2 were used as the study subjects; cell survival rate was detected by sulfonylrhodamine B(SRB); the mRNA level of key genes for fatty acid synthesis was detected by qPCR; the protein level of the AMPK/ACC pathway was detected by Western blot; intracellular lipid metabolites were examined by liquid chromatography-mass spectrometry(LC-MS). Results Comparing to control group, CTO significantly decreased the cell viability of AsPC-1, AR, PANC-1, and MiaPaCa-2(P＜0.05). CTO down-regulated the mRNA level of key fatty acid synthesis genes(P＜0.05). CTO significantly reduced the protein expression of AMPK, ACC and c-Myc(P＜0.05), while increasing the protein expression of p-AMPK and p-ACC(P＜0.05). CTO decreased lipid metabolite content in AR cells(P＜0.05). Conclusions CTO attenuates cellular fatty acid anabolism by inhibition of oncogene c-Myc expression and AMPK/ACC pathway, down-regulates the expression of fatty acid synthesis-related genes, and then inhibits proliferation of the human pancreatic cancer cell lines AsPC-1, AR, PANC-1 and MiaPaCa-2.

Key words: carboxyamidotriazole-orotate, pancreatic cancer, proliferation, fatty acid anabolism

中图分类号:

郭泓江, 徐也婷, 张迪雅, 仇佳星, 王钰铖, 鞠瑞, 郭磊. 羧胺三唑乳清酸盐对人胰腺癌细胞系增殖及脂肪酸合成代谢的影响[J]. 基础医学与临床, 2024, 44(4): 440-446.

GUO Hongjiang, XU Yeting, ZHANG Diya, QIU Jiaxing, WANG Yucheng, JU Rui, GUO Lei. Effect of carboxyamidotriazole-orotate on proliferation and fatty acid anabolism of human pancreatic cancer cell lines[J]. Basic & Clinical Medicine, 2024, 44(4): 440-446.

参考文献 14

[1]	Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73:17-48.
[2]	Rahib L, Wehner MR, Matrisian LM, et al. Estimated projection of US cancer incidence and death to 2040[J]. JAMA Netw Open, 2021, 4: e214708. doi:10.1001/jamanetworkopen.2021.4708.
[3]	Kim MP, Gallick GE. Gemcitabine resistance in pancre-atic cancer: picking the key players[J]. Clin Cancer Res, 2008, 14:1284-1285.
[4]	Ju R, Guo L, Li J, et al. Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anti-cancer effect with glycolysis inhibition[J]. Cancer Lett, 2016, 370:232-241.
[5]	Shi J, Ju R, Gao H, et al. Targeting glutamine utilization to block tumour cells metabolic adaptation under the stress of carboxyamidotriazole-induced nutrients unavailability[J]. Acta Pharmaceutica Sinica B, 2022, 12: 759-773.
[6]	Metallo CM, Gameiro PA, Bell EL, et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia[J]. Nature, 2011, 481:380-384.
[7]	Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression[J]. Science, 2020, 368: eaaw5473. doi:10.1126/science.aaw5473.
[8]	Gu Z, Du Y, Zhao X, et al. Tumor microenvironment and metabolic remodeling in gemcitabine-based chemoresistance of pancreatic cancer[J]. Cancer Lett, 2021, 521:98-108.
[9]	Currie E, Schulze A, Zechner R, et al. Cellular fatty acid metabolism and cancer[J]. Cell Metab, 2013, 18:153-161.
[10]	Carracedo A, Cantley LC, Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight[J]. Nat Rev Cancer, 2013, 13:227-232.
[11]	Gao L, Xu Z, Huang Z, et al. CPI-613 rewires lipid metabolism to enhance pancreatic cancer apoptosis via the AMPK-ACC signaling[J]. J Exp Clin Cancer Res, 2020, 39:73. doi:10.1186/s13046-020-01579-x.
[12]	Bian X, Liu R, Meng Y, et al. Lipid metabolism and cancer[J]. J Exp Med, 2021, 218: e20201606. doi:10.1084/jem.20201606.
[13]	Gouw AM, Margulis K, Liu NS, et al. The MYC oncogene cooperates with sterol-regulated element-binding protein to regulate lipogenesis essential for neoplastic growth[J]. Cell Metab, 2019, 30:556-572.
[14]	Chen J, Ding C, Chen Y, et al. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway[J]. Cancer Lett, 2021, 502:154-165.

[1]	王婷婷, 萧宁, 林佃新, 董海涛. 大蒜素抑制口腔癌细胞系CAL27的增殖[J]. 基础医学与临床, 2024, 44(5): 673-676.
[2]	贾安娜, 郭金鑫, 张璇, 战世佳, 于永波, 郭永丽, 常艳. TMEFF1对神经母细胞瘤细胞系增殖的调控[J]. 基础医学与临床, 2024, 44(5): 637-644.
[3]	梁香存, 魏小雨, 梁健, 王庆, 耿广. 安罗替尼通过调控miR-16-5p/PD-1轴抑制人非小细胞肺癌细胞系增殖并促进凋亡[J]. 基础医学与临床, 2024, 44(4): 503-512.
[4]	陆凯, 陆建菊, 郭文利, 黄建棋, 李志华. lncRNA VIM-AS5在人乳腺癌细胞系中的表达及对乳腺癌细胞增殖和迁移的影响[J]. 基础医学与临床, 2024, 44(4): 447-453.
[5]	李娜, 李涛, 杨冬梨, 姚媛. 和厚朴酚抑制人脂肪间充质干细胞增殖[J]. 基础医学与临床, 2024, 44(4): 483-488.
[6]	张婧, 杨自更, 蔡文琴, 曹维维, 韦红梅, 薛茜茜, 吴宾. 抑制抗增殖蛋白2增强非小细胞肺癌细胞系A549对厄洛替尼敏感性[J]. 基础医学与临床, 2024, 44(3): 325-332.
[7]	安琪, 齐光照, 韩超. 桃叶珊瑚苷抑制人肝癌细胞系HepG2增殖[J]. 基础医学与临床, 2024, 44(3): 333-338.
[8]	贾安娜, 战世佳, 张璇, 郭金鑫, 于永波, 郭永丽, 常艳. C12ORF66对MYCN扩增的高危神经母细胞瘤细胞的活性调控[J]. 基础医学与临床, 2024, 44(3): 288-294.
[9]	方媛, 李轶, 王玮. CircRERE调节miR-128-3p/WEE1轴促进人多发性骨髓瘤细胞系增殖、迁移和侵袭[J]. 基础医学与临床, 2024, 44(2): 210-218.
[10]	郭艳芳, 耿超, 解相宏, 陈恩惠, 郭泽宇, 张明龙, 刘晓军. Sestrin1参与调控小鼠肝脏细胞糖异生[J]. 基础医学与临床, 2024, 44(2): 141-146.
[11]	廖镇城, 杨思懿, 吴平安. 提高m⁶A去甲基化酶FTO表达抑制鼻咽癌细胞增殖[J]. 基础医学与临床, 2024, 44(1): 57-62.
[12]	余洁, 马明磊, 张化冰, 平凡, 李伟, 许岭翎, 李玉秀. miR-139-5p增强二甲双胍抑制正常糖培养下人胰腺癌细胞系PANC-1增殖[J]. 基础医学与临床, 2024, 44(1): 8-15.
[13]	李江丽, 孙静, 唐一君, 郭君兰, 陈博, 郭胜男. Circ-DDX5靶向miR-3940抑制人乳腺癌细胞系的增殖和侵袭[J]. 基础医学与临床, 2024, 44(1): 1-7.
[14]	潘闪, 林铿强, 陈树兴. 培美曲塞抑制人肺腺癌细胞系A549增殖[J]. 基础医学与临床, 2023, 43(9): 1359-1363.
[15]	朱锋, 钟粤, 邓义江, 刘文值, 边疆. 右美托咪定通过上调PPAR-γ改善神经病理性疼痛模型大鼠的痛觉敏化[J]. 基础医学与临床, 2023, 43(9): 1369-1374.

羧胺三唑乳清酸盐对人胰腺癌细胞系增殖及脂肪酸合成代谢的影响

Effect of carboxyamidotriazole-orotate on proliferation and fatty acid anabolism of human pancreatic cancer cell lines

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 14

相关文章 15

编辑推荐

Metrics

本文评价